Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Expanded Access
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient has relapsed/refractory disease and exhausted all standard treatments.
The patient has documented Breast Cancer (BRCA), BRCA associated RING domain (BARD), or Partner and Localizer of Breast Cancer (PALB) or other acceptable deoxyribonucleic acid (DNA) mutations.
You may not be if
The patient is eligible for a Poly Adenosine diphosphate ribose polymerase (PARP) inhibitor clinical trial.
The patient has previously received a PARP inhibitor for the same disease.
